Policy and Medicine (@policymed) profile picture

The latest information on healthcare transparency, compliance and medical education

Washington, DC
Joined May 2009
Photo by Policy and Medicine (@policymed)Photo by Policy and Medicine (@policymed)Photo by Policy and Medicine (@policymed)Photo by Policy and Medicine (@policymed)Photo by Policy and Medicine (@policymed)Photo by Policy and Medicine (@policymed)Photo by Policy and Medicine (@policymed)Photo by Policy and Medicine (@policymed)Photo by Policy and Medicine (@policymed)Photo by Policy and Medicine (@policymed)
The OMB concluded their review of FDA DTC advertising rule on 10/26, Direct-to-Consumer Prescription Drug Advertisements: Presentation of the Major Statement in a Clear, Conspicuous, Neutral Manner in Advertisements in Television and Radio Format: look for it 10/31 or 11/01
110
New post: Bipartisan Senators Ask for Additional Guidance on Transparency in Coverage Rule Recently, a bipartisan duo of policymed.com/?p=16093
1
111
New post: Congress Seeking Answers on Hospital Price Transparency Rule Compliance Recently, members of the Unite policymed.com/?p=16091
1
107
New post: CMS Fines Hospital for Noncompliance with Hospital Price Transparency Rule Recently, the Centers for Medi policymed.com/?p=16085
1
71
New post: House Subcommittee Focuses on Antimicrobial Resistance On April 28, 2023, the United policymed.com/?p=16083
1
68
New post: SouthEast Eye Specialists to Pay $17 Million to Resolve Anti-Kickback and False Claims Act Allegations It was recently announced that policymed.com/?p=16081
1
51
New post: FDA to Require Mail-Back Envelopes for Opioids Dispensed in Outpatient Settings Recently, the United States Fo policymed.com/?p=16078
1
70
New post: CCO MATE ACT DEA Resource Center Includes, Courses, Frequently Asked Questions (FAQ’s) and Additional Resources In December 2022, congress pas policymed.com/?p=16125
1
68
New post: OPDP: No More Untitled Letters? Today marks one year since the policymed.com/?p=16098
1
61
New post: PhRMA Releases Report on Global Prescription Drug Access The Pharmaceutical Research an policymed.com/?p=16035
1
54
New post: The Impact of COVID-19 Years on the ACO REACH Model The impact of the COVID-19 pan policymed.com/?p=16057
1
52
New post: PhRMA Focuses on Other Important Health Care System Improvements The Pharmaceutical Research an policymed.com/?p=16054
1
40
New post: Pioneer Institute Issues White Paper on Impact of PBMs and Copay Accumulator Programs The Pioneer Institute recently policymed.com/?p=16052
1
55
New post: AMA Survey Finds that Prior Authorization Harms Patient Care A recent physician survey foun policymed.com/?p=16050
1
18
New post: HHS OIG Releases Telehealth HHS OIG Toolkit HHS OIG has said that during 2 policymed.com/?p=16048
1
35
New post: CMS Outlines Medicare Drug Price Negotiation Program for 2026 On March 15, 2023, CMS release policymed.com/?p=16045
1
55
New post: CMS Releases 2024 MA Capitation Rates and Part C and D Payment Policies On Friday, March 31, 2023, the policymed.com/?p=16043
1
29
New post: Ongoing Litigation Over ACA Provisions that Mandate Health Coverage On March 30, 2023, the U.S. Di policymed.com/?p=16041
1
32
New post: Medical Societies Support Legislation Aimed at Updating Medicare The American Medical Associati policymed.com/?p=16039
1
39
New post: Stakeholders Provide Insight to CDER on Educational Needed in Rare Disease Development The United States Food and Dru policymed.com/?p=16037
1
95